Area of Science:

• Pharmacology
• Nephrology
• Traditional Chinese Medicine

Background:

• Spatholobus suberectus (SS) is a traditional Asian herb used for anemia, menoxenia, and rheumatism.
• The effects of SS on diabetes-induced renal damage and its mechanisms against advanced glycation end-products (AGEs) remain unclear.

Purpose of the Study:

• To evaluate the therapeutic effects of SS on diabetes-induced renal damage in a mouse model.
• To explore the underlying mechanisms of SS action, particularly concerning AGEs and oxidative stress.

Main Methods:

• db/db type 2 diabetic mice were orally administered SS extract (50 mg/kg) for 6 weeks.
• Evaluated changes in body weight, blood glucose, HbA1c, lipid profiles, and urinary albumin/creatinine ratio.
• Assessed protein expression of Nrf2, Glo1, NQO1, and CML; analyzed kidney tissue histology and AGEs accumulation.

Main Results:

• SS treatment did not alter body weight, blood glucose, or HbA1c levels.
• SS reversed diabetes-induced dyslipidemia and reduced urinary albumin/creatinine ratio.
• SS upregulated Nrf2, Glo1, and NQO1 expression, decreased CML accumulation, and downregulated RAGE.
• Histological analysis showed decreased PAS staining and AGEs accumulation in SS-treated kidneys.

Conclusions:

• SS ameliorates renal damage in type 2 diabetes by inhibiting glucotoxicity, dyslipidemia, and oxidative stress.
• The protective effects are mediated through the Nrf2/antioxidant responsive element (ARE) stress-response pathway.
• SS demonstrates potential as a therapeutic agent for diabetic nephropathy.